Home › Funds › Foresite Capital Management VI LLC › JBIO

Foresite Capital Management VI LLC position in JBIO

JADE BIOSCIENCES INC · Health Care

Foresite Capital Management VI LLC reported holding 886,667 shares of JBIO (JADE BIOSCIENCES INC) in its Q2 2026 13F filing — a position valued at US$19.7M, representing 3.07% of its reported portfolio and ranking #10 among its reported holdings. Foresite Capital Management VI LLC has disclosed JBIO holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

Latest position (Q2 2026)886.67K sh
Reported value held$19.70M
Portfolio Weight3.07%
First reportedQ1 2026
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Foresite Capital Management VI LLC's JBIO position evolved

Foresite Capital Management VI LLC first disclosed a stake in JBIO in Q1 2026 at 320,000 shares (US$4.5M). The position peaked in Q2 2026 at 886,667 shares, worth US$19.7M. Across 2 filings, Foresite Capital Management VI LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 886,667 shares valued at US$19.7M — an increase of 566,667 shares quarter over quarter.. Notable position changes include a 177% increase in Q2 2026 (shares fell 37% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2026 320.00K $4.50M New
Q2 2026 886.67K $19.70M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JBIO and 13F data

JBIO (JADE BIOSCIENCES INC) is a Health Care company. 106 other funds we track also report a position in JBIO — the largest reported positions include Fairmount Funds Management LLC (US$101.2M), RA CAPITAL MANAGEMENT, L.P. (US$81.6M), Venrock Adviser, LLC (US$71.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JBIO

All JBIO fund holders →

FAQ

How long has Foresite Capital Management VI LLC held JBIO?

Foresite Capital Management VI LLC has disclosed JBIO holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

What is Foresite Capital Management VI LLC's current position in JBIO?

As of Q2 2026, Foresite Capital Management VI LLC holds 886.67K shares of JBIO (JADE BIOSCIENCES INC), valued at $19.70M, representing 3.07% of its reported portfolio and ranking #10.

Has Foresite Capital Management VI LLC been buying or selling JBIO?

In the latest 13F filing (Q2 2026), Foresite Capital Management VI LLC increased its position in JBIO. The position peaked in Q2 2026 at 886.67K shares.

Which other funds hold JBIO?

Other major institutional holders of JBIO include Fairmount Funds Management LLC, RA CAPITAL MANAGEMENT, L.P., Venrock Adviser, LLC, among 106 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.